Intermediate products for producing oxazolidinone-quinolone hybrids

Details for Australian Patent Application No. 2004270379 (hide)

Owner Morphochem Aktiengesellschaft fuer kombinatorische Chemie

Inventors Specklin, Jean-Luc; Baeschlin, Daniel K.; Surivet, Jean Philippe; Hubschwerlen, Christian

Agent Watermark

Pub. Number AU-B-2004270379

PCT Pub. Number WO2005/023801

Priority 103 40 485.6 03.09.03 DE

Filing date 3 September 2004

Wipo publication date 17 March 2005

Acceptance publication date 31 March 2011

International Classifications

C07D 263/20 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023801 Priority application(s): WO2005/023801

25 November 2010 Alteration of Name

  The name of the applicant has been altered to Morphochem Aktiengesellschaft fuer kombinatorische Chemie

31 March 2011 Application Accepted

  Published as AU-B-2004270379

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270389-Force-introduction point in core composites and method for producing said point using reinforcement elements that traverse the thickness of the core composite

2004270361-Malonamide derivatives blocking the activity of gama-secretase